Takeda Pharmaceutical Company Ltd
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Study of TAK-019 in Healthy Japanese Adults (COVID-19)
- Conditions
- Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
- Interventions
- Biological: TAK-019Biological: Placebo
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 200
- Registration Number
- NCT04712110
- Locations
- 🇯🇵
Nishi Kumamoto Hospital, Kumamoto, Japan
🇯🇵Sumida Hospital, Sumida-ku, Tokyo, Japan
A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease
- Conditions
- Crohn's DiseaseComplex Perianal Fistula
- Interventions
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 7
- Registration Number
- NCT04701411
- Locations
- 🇮🇱
Shamir Medical Center (Assaf Harofeh), Be'er Ya'aqov, Israel
🇮🇱Rambam Health Care Campus, Haifa, Israel
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema
- Conditions
- Hereditary Angioedema
- Interventions
- Drug: TAK-743 300 mg
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Takeda
- Target Recruit Count
- 12
- Registration Number
- NCT04687137
- Locations
- 🇯🇵
Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan
🇯🇵Kobe University Hospital, Kobe, Hyogo, Japan
🇯🇵Tokai University Hospital, Isehara, Kanagawa, Japan
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- Conditions
- Thrombotic Thrombocytopenic Purpura (TTP)
- Interventions
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 77
- Registration Number
- NCT04683003
- Locations
- 🇺🇸
Childrens Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
A Study of TAK-919 in Healthy Japanese Adults (COVID-19)
- Conditions
- Coronavirus Disease (COVID-19)
- Interventions
- Biological: TAK-919Biological: Placebo
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 200
- Registration Number
- NCT04677660
- Locations
- 🇯🇵
Sumida Hospital, Sumida-ku, Tokyo, Japan
🇯🇵PS Clinic, Fukuoka, Japan
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Takeda
- Target Recruit Count
- 10
- Registration Number
- NCT04668157
- Locations
- 🇯🇵
National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa, Japan
🇯🇵Miyagi Children's Hospital, Sendai, Miyagi, Japan
🇯🇵Hiroshima Prefectural Hospital, Hiroshima, Japan
A Study to Collect Information of People With Narcolepsy in Spain
- Conditions
- Narcolepsy
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 214
- Registration Number
- NCT04667338
- Locations
- 🇪🇸
Hospital Clinic de Barcelona, Barcelona, Cataluna, Spain
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
- Conditions
- Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Takeda
- Target Recruit Count
- 240
- Registration Number
- NCT04659798
- Locations
- 🇪🇸
H. Universitari Son Espases, Palma de Mallorca, Islas Baleares, Spain
🇪🇸Hospital General Universitario Santa Lucia, Cartagena, Murcia, Spain
🇪🇸H. Universitario de Leon, Leon, Castilla Y Leon, Spain
A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2
- Registration Number
- NCT04654351
- Locations
- 🇯🇵
Aich Medical University Hospital, Nagakute, Aichi, Japan
🇯🇵Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan
🇯🇵Kagoshima University Hospital, Kagoshima, Japan
Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe
- Conditions
- Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Takeda
- Target Recruit Count
- 686
- Registration Number
- NCT04597905
- Locations
- 🇫🇷
Carenity, Paris, France